Thursday, June 4, 2020
wellness India Expo
Home Tags Cipla

Tag: Cipla

“We aim to bring newer drug innovations to the Indian market”

Mentioned Luca Visini, Managing Director, Eli Lilly & Company India in an exclusive interaction with BioVoice where he outlined the goals of his company driven by innovation including pursual of new drug development and working towards medicines reaching people at large through different channels.....................

CDRI Lucknow celebrates its 69th annual day, hosts talk by Cipla...

"We are at the threshold of an Indian scientific revolution. This requires us to rethink, redesign and rebuilt our scientific base through appropriate technology” said Dr Y K Hamied while delivering the 45th Sir Mellanby oration.......................

Cipla Foundation sets up a state-of-the-art chemistry laboratory at IISER Pune

The lab aims to provide practical training in Chemistry to undergraduates and researchers in the varsity campus along with support to the national outreach programme for school children..................

CSIR-CDRI and Cipla signed an agreement for collaboration to develop new...

CSIR-CDRI and Cipla's public-private-partnership for research and development is expected to pave the way for new innovative drugs................

Cipla acquires novel anti-infective Elores to further anti-microbial stewardship in critical...

Product to strengthen Cipla’s historic leadership in the anti-infectives space in India, and reinforce play in the Indian branded market. Acquisition in keeping with Cipla’s legacy of access to life-saving drugs and work in anti-microbial stewardship..............

Alvotech & Cipla Gulf join hands to commercialize key biosimilar in...

Under the partnership, Alvotech will be responsible for development and supply of AVT02, an adalimumab biosimilar, in select emerging markets., while Cipla Gulf will be responsible for registration and commercialization....................

Cipla USA furthers AMR stewardship with acquisition of key anti-infective ZEMDRI

Cipla USA to hold worldwide rights (excluding Greater China) of ZEMDRI™ (IV Plazomicin), an IV aminoglycoside with once-daily dosing for cUTI in adults, with proven activity against certain drug-resistant bacteria.......................

22 drugs in the market without approval, govt sends notices to...

The NPPA has so far issued demand notices for an amount of Rs 101 crore against defaulting companies. Out of this, an amount of Rs. 5.56 crore has been recovered and demand notices amounting to Rs. 89.31 crore are under litigation....................

Cipla EU & Jiangsu Acebright enter into a joint venture

According to the agreement, Cipla EU will hold an 80% stake and Acebright will hold a 20% stake in it for a combined investment of USD 30mn. Upon incorporation, the JV Co will set up a manufacturing facility for local manufacture of respiratory products.............

Cipla appoints Dr Raju Mistry as Global Chief People Officer

In her role at Cipla, Raju will oversee Human Resources, and Administration and Facilities Management......................